Cargando…
Increased mortality associated with frequent exacerbations in COPD patients with mild-to-moderate lung function impairment, and smokers with normal spirometry
BACKGROUND: The burden of frequent respiratory exacerbations in COPD patients with mild-to-moderate spirometric impairment and smokers with preserved lung function is unknown. METHODS: We categorized COPD participants in COPDGene with post-bronchodilator FEV1%predicted≥50% by the annual exacerbation...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333066/ https://www.ncbi.nlm.nih.gov/pubmed/35911870 http://dx.doi.org/10.1016/j.yrmex.2020.100025 |
_version_ | 1784758800575627264 |
---|---|
author | Fortis, Spyridon Wan, Emily S. Kunisaki, Ken Eyck, Patrick Tel Ballas, Zuhair K. Bowler, Russell P. Crapo, James D. Hokanson, John E. Wendt, Chris Silverman, Edwin K. Comellas, Alejandro P. |
author_facet | Fortis, Spyridon Wan, Emily S. Kunisaki, Ken Eyck, Patrick Tel Ballas, Zuhair K. Bowler, Russell P. Crapo, James D. Hokanson, John E. Wendt, Chris Silverman, Edwin K. Comellas, Alejandro P. |
author_sort | Fortis, Spyridon |
collection | PubMed |
description | BACKGROUND: The burden of frequent respiratory exacerbations in COPD patients with mild-to-moderate spirometric impairment and smokers with preserved lung function is unknown. METHODS: We categorized COPD participants in COPDGene with post-bronchodilator FEV1%predicted≥50% by the annual exacerbation frequency into three groups: i)frequent exacerbators (top 5%; n = 109), ii)exacerbators (>0 but less than frequent exacerbators; n = 1,009), and iii)No exacerbation (n = 981). Exacerbations were defined as respiratory episodes requiring antibiotics and/or systemic steroids. We performed a Cox proportional hazards regression analysis to examine the association with mortality. We repeated the same process in current/former smokers with preserved spirometry (FEV1≥80%predicted and FEV1/FVC≥0.7). RESULTS: Among 2,099 COPD participants, frequent exacerbators had ≥1.8 exacerbations/year and were responsible for 34.3% of the total exacerbations. There were 102 (10.4%) deaths in the group with no exacerbations, 119 (11.8%) in the exacerbator group, and 24 (22%) in the frequent exacerbators. Adjusted mortality in frequent exacerbators was higher relative to individuals with no exacerbations (hazard ratio (HR) = 1.98; 95%CI = 1.25–3.13). An increase in frequency of exacerbations by one exacerbation/year was associated with increased mortality (HR = 1.40,95%CI = 1.21–1.62). Among 3,143 participants with preserved spirometry, frequent exacerbators had ≥0.8 exacerbations/year and were responsible for more than half of the exacerbations. There were 93 (4.2%) deaths in the group with no exacerbations, 28 (3.8%) in the exacerbator group, and 14 (7.6%) in the frequent exacerbators. The adjusted mortality was increased in frequent exacerbators with preserved spirometry relative to those with no exacerbations (HR = 2.25; 95%CI = 1.26–4.01). CONCLUSIONS: In COPD participants with mild-to-moderate spirometric impairment and smokers with preserved spirometry, the frequent exacerbator phenotype is responsible for a large proportion of total exacerbations and associated with high mortality. |
format | Online Article Text |
id | pubmed-9333066 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
record_format | MEDLINE/PubMed |
spelling | pubmed-93330662022-07-28 Increased mortality associated with frequent exacerbations in COPD patients with mild-to-moderate lung function impairment, and smokers with normal spirometry Fortis, Spyridon Wan, Emily S. Kunisaki, Ken Eyck, Patrick Tel Ballas, Zuhair K. Bowler, Russell P. Crapo, James D. Hokanson, John E. Wendt, Chris Silverman, Edwin K. Comellas, Alejandro P. Respir Med X Article BACKGROUND: The burden of frequent respiratory exacerbations in COPD patients with mild-to-moderate spirometric impairment and smokers with preserved lung function is unknown. METHODS: We categorized COPD participants in COPDGene with post-bronchodilator FEV1%predicted≥50% by the annual exacerbation frequency into three groups: i)frequent exacerbators (top 5%; n = 109), ii)exacerbators (>0 but less than frequent exacerbators; n = 1,009), and iii)No exacerbation (n = 981). Exacerbations were defined as respiratory episodes requiring antibiotics and/or systemic steroids. We performed a Cox proportional hazards regression analysis to examine the association with mortality. We repeated the same process in current/former smokers with preserved spirometry (FEV1≥80%predicted and FEV1/FVC≥0.7). RESULTS: Among 2,099 COPD participants, frequent exacerbators had ≥1.8 exacerbations/year and were responsible for 34.3% of the total exacerbations. There were 102 (10.4%) deaths in the group with no exacerbations, 119 (11.8%) in the exacerbator group, and 24 (22%) in the frequent exacerbators. Adjusted mortality in frequent exacerbators was higher relative to individuals with no exacerbations (hazard ratio (HR) = 1.98; 95%CI = 1.25–3.13). An increase in frequency of exacerbations by one exacerbation/year was associated with increased mortality (HR = 1.40,95%CI = 1.21–1.62). Among 3,143 participants with preserved spirometry, frequent exacerbators had ≥0.8 exacerbations/year and were responsible for more than half of the exacerbations. There were 93 (4.2%) deaths in the group with no exacerbations, 28 (3.8%) in the exacerbator group, and 14 (7.6%) in the frequent exacerbators. The adjusted mortality was increased in frequent exacerbators with preserved spirometry relative to those with no exacerbations (HR = 2.25; 95%CI = 1.26–4.01). CONCLUSIONS: In COPD participants with mild-to-moderate spirometric impairment and smokers with preserved spirometry, the frequent exacerbator phenotype is responsible for a large proportion of total exacerbations and associated with high mortality. 2021-11 2020-12-29 /pmc/articles/PMC9333066/ /pubmed/35911870 http://dx.doi.org/10.1016/j.yrmex.2020.100025 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ). |
spellingShingle | Article Fortis, Spyridon Wan, Emily S. Kunisaki, Ken Eyck, Patrick Tel Ballas, Zuhair K. Bowler, Russell P. Crapo, James D. Hokanson, John E. Wendt, Chris Silverman, Edwin K. Comellas, Alejandro P. Increased mortality associated with frequent exacerbations in COPD patients with mild-to-moderate lung function impairment, and smokers with normal spirometry |
title | Increased mortality associated with frequent exacerbations in COPD patients with mild-to-moderate lung function impairment, and smokers with normal spirometry |
title_full | Increased mortality associated with frequent exacerbations in COPD patients with mild-to-moderate lung function impairment, and smokers with normal spirometry |
title_fullStr | Increased mortality associated with frequent exacerbations in COPD patients with mild-to-moderate lung function impairment, and smokers with normal spirometry |
title_full_unstemmed | Increased mortality associated with frequent exacerbations in COPD patients with mild-to-moderate lung function impairment, and smokers with normal spirometry |
title_short | Increased mortality associated with frequent exacerbations in COPD patients with mild-to-moderate lung function impairment, and smokers with normal spirometry |
title_sort | increased mortality associated with frequent exacerbations in copd patients with mild-to-moderate lung function impairment, and smokers with normal spirometry |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333066/ https://www.ncbi.nlm.nih.gov/pubmed/35911870 http://dx.doi.org/10.1016/j.yrmex.2020.100025 |
work_keys_str_mv | AT fortisspyridon increasedmortalityassociatedwithfrequentexacerbationsincopdpatientswithmildtomoderatelungfunctionimpairmentandsmokerswithnormalspirometry AT wanemilys increasedmortalityassociatedwithfrequentexacerbationsincopdpatientswithmildtomoderatelungfunctionimpairmentandsmokerswithnormalspirometry AT kunisakiken increasedmortalityassociatedwithfrequentexacerbationsincopdpatientswithmildtomoderatelungfunctionimpairmentandsmokerswithnormalspirometry AT eyckpatricktel increasedmortalityassociatedwithfrequentexacerbationsincopdpatientswithmildtomoderatelungfunctionimpairmentandsmokerswithnormalspirometry AT ballaszuhairk increasedmortalityassociatedwithfrequentexacerbationsincopdpatientswithmildtomoderatelungfunctionimpairmentandsmokerswithnormalspirometry AT bowlerrussellp increasedmortalityassociatedwithfrequentexacerbationsincopdpatientswithmildtomoderatelungfunctionimpairmentandsmokerswithnormalspirometry AT crapojamesd increasedmortalityassociatedwithfrequentexacerbationsincopdpatientswithmildtomoderatelungfunctionimpairmentandsmokerswithnormalspirometry AT hokansonjohne increasedmortalityassociatedwithfrequentexacerbationsincopdpatientswithmildtomoderatelungfunctionimpairmentandsmokerswithnormalspirometry AT wendtchris increasedmortalityassociatedwithfrequentexacerbationsincopdpatientswithmildtomoderatelungfunctionimpairmentandsmokerswithnormalspirometry AT silvermanedwink increasedmortalityassociatedwithfrequentexacerbationsincopdpatientswithmildtomoderatelungfunctionimpairmentandsmokerswithnormalspirometry AT comellasalejandrop increasedmortalityassociatedwithfrequentexacerbationsincopdpatientswithmildtomoderatelungfunctionimpairmentandsmokerswithnormalspirometry |